Mark Danby
Private Equity Investor bei Pollen Street Capital Ltd.
Profil
Mr. Mark Danby is a Principal at Pollen Street Capital Ltd.
He is on the Board of Directors at The Gada Group Ltd.
He received his undergraduate degree from London Business School and a graduate degree from London Business School.
Aktive Positionen von Mark Danby
Unternehmen | Position | Beginn |
---|---|---|
Pollen Street Capital Ltd.
Pollen Street Capital Ltd. Investment ManagersFinance Pollen Street Capital Ltd (Pollen Street Capital) is a private equity firm founded in 1980 by Lindsey Villon McMurray. Pollen Street Capital Ltd. is headquartered in London, the United Kingdom. | Private Equity Investor | 26.07.2011 |
Ehemalige bekannte Positionen von Mark Danby
Unternehmen | Position | Ende |
---|---|---|
The Gada Group Ltd.
The Gada Group Ltd. Medical DistributorsDistribution Services The Gada Group Ltd. provides medical technology devices and equipment. The firm offers automated blood collections, therapeutic apheresis dialysis, laboratory and transfusion, cardiovascular, general hospital and perfusion. The company was incorporated on August 11, 2004 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 31.01.2013 |
Ausbildung von Mark Danby
London Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pollen Street Capital Ltd.
Pollen Street Capital Ltd. Investment ManagersFinance Pollen Street Capital Ltd (Pollen Street Capital) is a private equity firm founded in 1980 by Lindsey Villon McMurray. Pollen Street Capital Ltd. is headquartered in London, the United Kingdom. | Finance |
The Gada Group Ltd.
The Gada Group Ltd. Medical DistributorsDistribution Services The Gada Group Ltd. provides medical technology devices and equipment. The firm offers automated blood collections, therapeutic apheresis dialysis, laboratory and transfusion, cardiovascular, general hospital and perfusion. The company was incorporated on August 11, 2004 and is headquartered in London, the United Kingdom. | Distribution Services |